ATG5 and cutaneous melanoma: Sec23a and Atg5 expression level were both significantly lower in skin cutaneous melanoma (SKCM) patients with advanced primary tumors and regional lymph node metastasis in comparison with SKCM patients of early stages (Fig. 6a–d).